Biliary Tract Cancer - 80 Studies Found
| Completed |
: A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers :
: 2012-07-24 :
|
| Terminated |
: Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study : Inoperable Locally Advanced or Metastatic Biliary Tract Cancer : 2013-09-10 :
|
| Recruiting |
: Study of Sulfatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma : Biliary Tract Cancer : 2016-11-11 : Drug: Sulfatinib Patients receive oral Sulfatinib at a dose of 300mg/d within 1 hour after breakfast (on |
| Not yet recruiting |
: Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) : Biliary Tract Cancer : 2017-04-12 :
|
| Recruiting |
: XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy : Biliary Tract Cancer : 2014-11-24 :
|
| Completed |
: Covered Versus Uncovered Biliary Stents for Biliary Malignancies : Biliary Tract Cancer : 2014-03-26 :
|
| Active, not recruiting |
: X-MAS Biliary Study With Covered Biliary Stent : Biliary Tract Cancer : 2013-07-08 : Device: X-Suit NIR Covered Biliary Stent |
| Completed |
: Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas : Biliary Tract Cancer : 2012-04-04 : Drug: Oxaliplatin, Fluorouracil, Leucovorin, Capecitabine HAI of Oxaliplatin and Fluorouracil: Oxaliplat |
| Terminated |
: A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma : Biliary Tract Cancer : 2009-04-13 : Drug: "Bevacizumab" in combination with "modified FOLFOX6". Oxaliplatin 85 mg/m2 IV |
| Not yet recruiting |
: Study of SPARC1507 : Advanced Biliary Tract Cancer : 2015-11-03 :
|